 |
I currently am a graduate student in Microbiology at the University of
Alabama at Birmingham. While the place is not as interesting as where I
did my under grad work, it has the advantage of having one of the top research
programs in the world on HIV (human immunodeficiency virus). I am currently
at work on a number of projects and my first first author paper in this
field will be coming out in the next several months.
. |
|
Just to provide a quick overview of HIV, the virus has a double stranded
RNA genome that is protected from the environment first by a protein capsid
and second by a lipid-protein membrane (as shown on the right). Even with
these protective layers the virus is relatively unstable outside of the
host and will usually be rendered non-infectious within an hour in the
environment. Unfortunately, in the body of its host, its high rate of infection
and its ability to maintain itself in a non-active form (latency) for years
makes its almost impossible to eradicate following a productive infection
of a new host. For this reason, research in this field is split into trying
to stop the virus prior to infection and trying to develop treatments for
those already infected |
 |
 |
My work
is focused on three major questions. The interplay of reverse transcription
and integration in the early events of retroviral replication, the interplay
of HIV with HERVs (human endogenous retroviruses), and the development
of gene therapy approaches for treatment of HIV infected individuals.
The interplay
of the integrase and reverse transciptase protein has been suggested by
several mutants and I am doing work to clarify if this interaction exists
and how it affects the early events that take place between the virion
fusing to the host cell and the viral DNA integrating into the host genome
(the steps of which are shown to the left). |
My second
project is devoted to work concerning if HERVs (retroviruses that have
been part of the human genome for several million years) can possibly enhance
or confer resistance to the HIV viruses present in that individual. My
third project is a gene therapy approach that is designed to render all
virions produced by the target cell non-infectious. This could effectively
stop the progression of HIV into AIDS.
I really
cannot go into any more detail on these areas of research as a consequence
of copyrights and the fact that work in these areas has not yet been completed.
If you have any questions on these areas or on HIV in general, I would
be glad to answer them via e-mail. |
If you are a bit curious how I got to working with HIV, I have to admit
the route was a bit circuitous. I started doing research in marine biology
and ecology in High School and actually did a short stint working for the
EPA as a research assistant prior to my entry into college. For the next
several years I worked as a part time lab tech at Duke's School of the
Environment doing work to set environmental standards for phosphate emissions
into wetland area. To avoid terminal boredom, I became a part time research
assistant at Duke's Pediatric Medical Genetics department my Junior and
senior year of college. I found I liked doing work that could directly
affect people and became fascinated with gene therapy. After a short summer
stint, working as a lab tech at Duke's Pediatric Cardiology division, I
entered the graduate program in Cellular and Molecular Biology at the University
of Alabama and this is where I will remain until I get my Ph.D. If you
are really interested in my background or if you have a nice position you
want to offer me, I would be glad to send you my CV. |
|